🇪🇺 Savaysa in European Union

EMA authorised Savaysa on 19 June 2015

Marketing authorisation

EMA — authorised 19 June 2015

  • Marketing authorisation holder: Daiichi Sankyo Europe GmbH
  • Status: approved

Savaysa in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in European Union

Frequently asked questions

Is Savaysa approved in European Union?

Yes. EMA authorised it on 19 June 2015.

Who is the marketing authorisation holder for Savaysa in European Union?

Daiichi Sankyo Europe GmbH holds the EU marketing authorisation.